Back
Exelixis Vs. BioCryst Pharmaceuticals Industry Stock Comparison
Buy
65
EXEL
Exelixis
Last Price:
26.84
Seasonality Move:
3.88%
Sell
38
BCRX
BioCryst Pharmaceuticals
Last Price:
8.16
Seasonality Move:
-9.69%
Buy
65
Exelixis (EXEL)
is a Buy
Is Exelixis a Buy, Sell or Hold?
- The current Exelixis [EXEL] share price is $26.83. The Score for EXEL is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- EXEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy, Sell or Hold?
- The current BioCryst Pharmaceuticals [BCRX] share price is $8.16. The Score for BCRX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EXEL Stock Price Chart
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals's stock price today?
-
The BioCryst Pharmaceuticals share price today is $8.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing slight buying pressure.
EXEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 59.35 | Buy |
| Chaikin Money Flow: | -486819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.63 - 26.79) | Buy |
| Bollinger Bands (100): | (21.31 - 25.51) | Buy |
BCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 57.44 | Buy |
| Chaikin Money Flow: | 110287 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.74 - 8.32) | Buy |
| Bollinger Bands (100): | (5.85 - 7.91) | Buy |
EXEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.8 | Buy |
| 20-day SMA: | 26.16 | Buy |
| 50-day SMA: | 25.05 | Buy |
| 200-day SMA: | 23 | Buy |
| 8-day EMA: | 26.75 | Buy |
| 20-day EMA: | 26.29 | Buy |
| 50-day EMA: | 25.25 | Buy |
| 200-day EMA: | 23.14 | Buy |
BCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.89 | Buy |
| 20-day SMA: | 8.09 | Buy |
| 50-day SMA: | 7.74 | Buy |
| 200-day SMA: | 6.18 | Buy |
| 8-day EMA: | 7.98 | Buy |
| 20-day EMA: | 7.96 | Buy |
| 50-day EMA: | 7.64 | Buy |
| 200-day EMA: | 6.77 | Buy |
Exelixis Earnings Growth & EXEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.02 per share, an increase this year of $0.93 per share, and a decrease next year of $0.05 per share.
BioCryst Pharmaceuticals Earnings Growth & BCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.23 per share.
Exelixis Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioCryst Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||